GE HealthCare Gains FDA Clearance for Revolution Vibe CT, First Installed in France

GE HealthCare has obtained 510(k) clearance from the U.S. Food and Drug Administration for its Revolution Vibe CT system, a technology aimed at enhancing coronary CT angiography. The first global installation has taken place at Radiologie du Var – ELSAN in southern France.

The system introduces “Unlimited One-Beat” imaging, capable of capturing the entire heart in a single beat, even without an ECG trace. Integrated AI-powered workflows have demonstrated reductions in exam time of up to 50% and the ability to double CCTA capacity through streamlined preparation and automated processes.

Engineered to address complex cases, Revolution Vibe is designed to handle patients with arrhythmias, calcifications, stents, or prior bypasses while maintaining low-dose imaging. Clinical evaluations showed consistent improvements in efficiency, patient throughput, and diagnostic confidence.

The adoption at Radiologie du Var adds to a fleet of advanced imaging systems supporting one of the highest cardiovascular imaging volumes in France. With FDA clearance secured, GE HealthCare plans broader deployment in the U.S., where demand for non-invasive cardiac imaging continues to rise.